Feng, W.-H.; Chang, Y.-C.; Lin, Y.-H.; Chen, H.-L.; Chang, H.-M.; Chu, C.-S.
Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. Int. J. Mol. Sci. 2022, 23, 4549.
https://doi.org/10.3390/ijms23094549
AMA Style
Feng W-H, Chang Y-C, Lin Y-H, Chen H-L, Chang H-M, Chu C-S.
Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. International Journal of Molecular Sciences. 2022; 23(9):4549.
https://doi.org/10.3390/ijms23094549
Chicago/Turabian Style
Feng, Wen-Han, Yong-Chieh Chang, Yi-Hsiung Lin, Hsiao-Ling Chen, Hsiu-Mei Chang, and Chih-Sheng Chu.
2022. "Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention" International Journal of Molecular Sciences 23, no. 9: 4549.
https://doi.org/10.3390/ijms23094549
APA Style
Feng, W.-H., Chang, Y.-C., Lin, Y.-H., Chen, H.-L., Chang, H.-M., & Chu, C.-S.
(2022). Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention. International Journal of Molecular Sciences, 23(9), 4549.
https://doi.org/10.3390/ijms23094549
